UNSPSC 51393410: Acefylline clofibrol

This classification denotes a bronchodilator with the molecular formula C19H21ClN4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WY672D78VW, chemically known as 7h-purine-7-acetic acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-, 2-(4-chlorophenoxy)-2-methylpropyl ester but more generally known as acefylline clofibrol, which bears US NIH Compound Identifier 68898. European Medicines Agency schedules Acefylline clofibrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05206MIG.

UNSPSC 51393410 Acefylline clofibrol is a Commodity code that state and local governments are using to tag pharmaceutical procurement, though the recent solicitation activity shows minimal direct alignment with the code's nominal scope. Seminole County, Florida, is soliciting naloxone and drug deactivation systems under this code classification, representing opioid-response and community health products rather than the specific pharmaceutical compound the code nominally describes. The mismatch between the code name and the actual procurement suggests that state and local procurement offices may be applying this Commodity code more broadly to pharmaceutical and medical-supply acquisitions than its title strictly indicates, or that the tagging reflects administrative categorization rather than precise commodity matching.

The single recent opportunity on record is Seminole County's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023 (note: date discrepancy in source), for 1,900 units of naloxone and 800 safe drug deactivation systems annually on a two-year contract with an optional one-year renewal. Delivery is quarterly to Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping costs. Bidders must meet E-Verify compliance, drug-free workplace certification, and standard insurance requirements including workers' compensation and commercial general liability. The procurement does not specify explicit set-aside designations. The limited activity under this code suggests either sparse recent demand or continued misclassification in state and local systems; the Florida activity alone does not establish a broader geographic or issuing-body pattern.